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Abstract
Epidemiological evidence is consistent with a protective effect of vitamin D
against colorectal cancer (CRC), but the observed strong associations are open to
confounders and potential reverse causation. Previous Mendelian randomisation
(MR) studies were limited by poor genetic instruments and inadequate statistical
power. Moreover, whether genetically higher CRC risk can influence vitamin D
level, namely the reverse causation, still remains unknown. Herein, we report the
first bidirectional MR study. We employed 110 newly identified genetic variants
as proxies for vitamin D to obtain unconfounded effect estimates on CRC risk in
26 397 CRC cases and 41 481 controls of European ancestry. To test for reserve
causation, we estimated effects of 115 CRC-risk variants on vitamin D level
among 417 580 participants from the UK Biobank. The causal association was
estimated using the random-effect inverse-variance weighted (IVW) method. We
found no significant causal effect of vitamin D on CRC risk [IVW estimate odds
ratio: 0.97, 95% confidence interval (CI) = 0.88-1.07, P = .565]. Similarly, no sig-
nificant reverse causal association was identified between genetically increased
CRC risk and vitamin D levels (IVW estimate β: 0.002, 95% CI = 0.008 to
0.004, P = .543). Stratified analysis by tumour sites did not identify significant
causal associations in either direction between vitamin D and colon or rectal can-
cer. Despite the improved statistical power of this study, we found no evidence of
causal association of either direction between circulating vitamin D and CRC risk.
Significant associations reported by observational studies may be primarily driven
by unidentified confounders.
Abbreviations: BMI, body mass index; CI, confidence interval; CRC, colorectal cancer; GWAS, genome-wide association study; IVW, inverse-variance weighted method; LD, linkage
disequilibrium; MR, Mendelian randomisation; OR, odds ratio; PRESSO, Pleiotropy Residual Sum and Outlier; SOCCS, the Study of Colorectal Cancer in Scotland.
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What's new?
Vitamin D is associated with outcomes of colorectal cancer (CRC), but a causal relationship
hasn't been established. Previous studies could not rule out that predisposition to CRC reduces
circulating vitamin D. Here, the authors report results from a bi-directional Mendelian randomi-
zation. Using 110 variants and 26,397 patients allowed for a statistically powerful analysis. They
found no causal relationship in either direction: low vitamin D did not increase CRC risk, and ele-
vated CRC risk did not reduce vitamin D levels. Previously observed associations, they suggest,
may be driven by unknown confounders.
1 | INTRODUCTION
Population-based observational studies consistently demonstrate
that lower circulating vitamin D levels are associated with a higher
risk of colorectal cancer (CRC).1 There has been increasing interest
in establishing whether this relationship is causal, because it would
provide the rationale for exploring dietary vitamin D supplements
for CRC prevention. All randomised trials to date, such as the VITAL
trial,2 have been underpowered to detect effects on CRC risk given
prohibitive cost and time to observe the required number of inci-
dent CRC cases. Mendelian randomisation (MR) is an alternative
approach to investigate causality.3 However, previous two MR
studies4,5 on vitamin D and CRC risk employed no more than six
known variants associated with vitamin D, and therefore were
hampered by poor genetic instruments (2.84% of vitamin D vari-
ance explained) which resulted in inadequate statistical power to
detect small to modest causal effects. A recent large genome-wide
association study (GWAS) including more than 400 000 Europeans
from the UK Biobank cohort identified 143 independent vitamin
D-related loci that could explain 5.7% to 10.5% of vitamin
D variance,6 allowing the development of a significantly improved
genetic instrument and therefore, a better powered MR study. In
addition, previous MR studies only investigated the vitamin D-CRC
association, and the null findings therefore could not exclude
reverse causation, namely that genetic predisposition to CRC could
possibly cause decreased circulating vitamin D concentration. Here,
we report a bidirectional MR using much improved genetic instru-
ments to explore whether the observed associations between vita-
min D and CRC risk are causal.
2 | MATERIALS AND METHODS
We adopted a two-sample MR approach to estimate causal effects in
both directions. To analyse the causal effect of vitamin D on CRC risk,
we created a genetic instrument using common variants (minor allele
frequency > 5%) identified from a recent GWAS on circulating vitamin
D concentration (P < 5  108) including 417 580 Europeans from
the UK Biobank cohort.6 Effect estimates of these variants along with
standard errors (SEs) were extracted from the same study. We then
assessed associations between these vitamin D variants and CRC risk
by conducting a meta-analysis of effect estimates from 14 GWASs on
TABLE 1 Summarised results of bidirectional Mendelian randomisation study on vitamin D and colorectal cancer risk
MR approach Cases/controls
Vitamin D-CRC CRC-vitamin D
OR (95% CI) P value N β (95% CI) P value
IVW 26 397/41 481 0.97 (0.88, 1.07) .565 417 580 0.002 (0.008, 0.004) .543
Median based 0.96 (0.84, 1.10) .569 0.001 (0.008, 0.009) .850
MR-Egger 1.03 (0.90, 1.17) .690 0.016 (0.001, 0.030) .039
MVMR 0.99 (0.88, 1.10) .790 0.002 (0.008, 0.004) .539
Stratified IVW
Colon 4281/24 599 0.91 (0.76, 1.09) .289 417 580 0.0002 (0.007, 0.007) .947
Rectum 3183/24 599 0.80 (0.55, 1.15) .229 0.001 (0.008, 0.006) .823
Abbreviations: CI, confidence interval; CRC, colorectal cancer; IVW, inverse-variance weighted; MR, Mendelian randomisation; MVMR, multi-variable
Mendelian randomisation; OR, odds ratio.
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CRC risk (26 397 cases and 41 481 controls),7 excluding the UK
Biobank cohort to control for possible bias introduced by over-
lapping participants.8 Statistical power was estimated using the
method described by Brion et al.9 Regarding the reverse causation,
we obtained summary effect estimates of CRC-risk variants
(P < 5  108) from two recent meta-analyses of GWASs on CRC
risk excluding UK Biobank samples.7,10 For overlapped variants
across the two studies, we retained the effect estimates with
smaller P values on CRC risk. Effects of these variants on vitamin
D concentration were then extracted from the published vitamin
D GWAS.6
We calculated the R2 statistic to evaluate linkage disequilibrium
(LD) among genetic variants. For any pair of variants in LD (R2 > 0.2),
we included the one with the smallest P value in relation to the
exposure. In an attempt to control for horizontal pleiotropy, we
excluded outlier variants using the MR-Pleiotropy Residual Sum
and Outlier (MR-PRESSO) approach.11 The strength of instruments
was assessed by calculating F-statistics (F < 10 was deemed as a
weak instrument).
Causal effect estimates were generated using the inverse-
variance weighted (IVW) method, which assumes all genetic vari-
ants as valid instruments.12 We also conducted additional analyses
F IGURE 1 Scatterplot of bidirectional Mendelian randomisation analyses [(A) Scatterplot of vitamin D-colorectal cancer risk MR; (B) Scatter
plot of colorectal cancer risk-vitamin D MR]. MR, Mendelian randomisation [Color figure can be viewed at wileyonlinelibrary.com]
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using the MR-Egger estimator assuming the presence of horizontal
pleiotropy,13 and the median-based estimator assuming half of the
genetic variants being invalid instruments.14 A P value <.008
(Bonferroni corrected threshold) was considered statistically signifi-
cant. In addition, epidemiological evidence found a potential role of
body mass index (BMI) in the vitamin D-CRC association,15 and
previous GWASs identified that vitamin D and CRC risk loci could
also be associated with BMI.6,7,16 Given the possible pleiotropic
effect introduced by BMI, we estimated bidirectional causal effects
between vitamin D and CRC risk using a multivariable MR
approach,17 leveraging genetic effect of instrumental variants on
BMI estimated from the UK Biobank.18 Previous observational
studies have reported differences between the vitamin D effect on
colonic cancer and rectal cancer.19 Thus, we also performed site-
stratified IVW MR analysis based on individual-level data of 4281
colon cancer, 3183 rectal cancer cases and 24 599 controls from
the Study of Colorectal Cancer in Scotland (SOCCS) and the UK
Biobank, and site-specific genetic variants as instruments for
reserve causation.20 All statistical analyses were performed using R
(version 3.6.1). Additional descriptions on the study cohorts, includ-
ing ethics approval, along with technical details of genotyping, qual-
ity control and genotype imputation have been published
elsewhere.6,7
3 | RESULTS
Following LD pruning and QC measures, 110 variants were included
as proxies of vitamin D level. Details of genetic variants selection
were presented in Figure S1 and basic characteristics along with
summary effect estimates of included variants on vitamin D are
presented in the Table S1. Using these 110 variants resulted in a
strong genetic instrument (assuming 5.7% of vitamin D variance
explained), with an F-statistic of 25 241. Based on 26 397 CRC
cases and 41 481 controls, the power of the MR analysis investigat-
ing the causal effect of vitamin D on CRC risk was 80% for an odds
ratio (OR) of 0.91 per SD increase of vitamin D concentration.
Summarised results of MR analysis using different estimators are
presented in Table 1. Using the IVW method, we identified null
causal effect of vitamin D on CRC risk [OR: 0.97 per unit of rank-
based inverse-normal transformed vitamin D concentration, 95%
confidence interval (CI) = 0.88-1.07, P = .565]. Effects of each vari-
ant on vitamin D and CRC risk are plotted in Figure 1A. No signifi-
cant effects were detected using the median-based estimator (OR:
0.96, 95% CI = 0.84-1.10, P = .569) and the MR-Egger method
(OR: 1.03, 95% CI = 0.90-1.17, P = .690). Test of intercept of the
MR-Egger estimator showed no significant horizontal pleiotropic
effects for the included variants (P = .220).
To evaluate any reverse causation effects, a total of 115 variants
associated with CRC risk were used as instruments. Effects of these
variants on vitamin D concentration were extracted from the previous
GWAS and can be found in the Table S2. We found that genetically
higher risk of CRC was not significantly associated with the vitamin D
concentration of 417 580 participants from the UK Biobank
cohort using the IVW estimator (β: 0.002, 95% CI = 0.008 to
0.004, P = .543, scatter plot in Figure 1B). Similarly, null causal effects
of CRC risk on vitamin D concentration were observed, after
Bonferroni correction, using either the median-based estimator (β:
0.001, 95% CI = 0.008 to 0.009, P = .850) or the MR-Egger method
(β: 0.016, 95% CI = 0.001-0.030, P = .039). MR-Egger analysis rev-
ealed suggestive evidence for horizontal pleiotropic effects for the
variants used as instruments (P = .011).
After controlling for possible pleiotropic effects of BMI, our multi-
variable MR analysis found no significant causal associations between
vitamin D concentration and CRC risk in either direction (Table 1).
Regarding stratified analysis, we failed to observe any significant
causal associations between vitamin D and colon or rectal cancer risk
(Tables 1, S3 and S4). A total of 38 variants associated with colon can-
cer and 26 variants associated with rectal cancer were included as
instruments to investigate site-specific reverse causation (Table S5),
and we did not observe any significant causal effects of genetically
higher risk of colon or rectal cancer on vitamin D level (Table 1).
4 | DISCUSSION
Since circulating vitamin D level is readily modifiable, there has been
growing interest in proving causality in the association between vita-
min D and CRC risk. Our study is an advance on prior knowledge in
the field, where we created a markedly more extensive genetic instru-
ment compared to our previous MRs (110 vs 6 variants). The genera-
tion of these genetic instruments, and the largest sample size to date
(26 397 cases), has enabled us to conduct statistically powerful ana-
lyses. Our findings provide robust evidence that even small-to-modest
causal effects of vitamin D on CRC risk are unlikely.
The strength of the genetic instrumental variable and our recent
GWAS on CRC risk has also allowed us to perform the first ever bidi-
rectional MR study.7 This is a novel aspect of considerable importance
to understanding whether a genetic predisposition to CRC can cause
decreased circulating vitamin D concentration, which was not
explored by the previous MR studies. Our results, however, do
not support this reverse causation. The null finding of reverse causa-
tion suggests that observed associations between vitamin D and CRC
in prospective studies are not due to reverse causality, and further
questions the role of vitamin D concentration in the biological mecha-
nisms of CRC progression.
In addition to enhanced power, strengths of this study also
include that we adopted multiple MR methods such as MR-PRESSO
and MR-Egger to detect possible pleiotropic effects of included
genetic instruments, which could potentially violate basic MR
assumptions.21 Large sample size, aligned with data granularity,
combined with the power of the genetic instruments that we
employed, also enabled us to explore the subsidiary aim of under-
standing the contribution of BMI as a potential confounding, but
modifiable effect. After controlling for BMI, our multivariable MR
analysis found no significant impact of BMI on vitamin D-CRC risk
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association in either direction. To explore the possibility that com-
bining colon and rectal cancer may underestimate the association
between vitamin D and a specific cancer location, we conducted a
stratified analysis using colon and rectal cancer specific instruments
and reran the bidirectional MR analysis. This analysis also con-
firmed lack of association between vitamin D and either colon or
rectal cancer, in either direction. The major limitation of this study
is the limited access to individual-level data to aggregate a large
enough sample size for further stratified analysis.
In conclusion, this is the first study to present bidirectional
assessment of the association between vitamin D and CRC risk using
MR. Our findings add to current knowledge by concluding that the
observed associations between vitamin D and CRC risk are most likely
driven by unknown confounders instead of possible reverse causation
or small to modest effects that failed to have been detected by previ-
ous MR studies with limited statistical power. Future efforts may
focus more on circulating vitamin D level as a predictive biomarker
instead of a therapeutic target for CRC prevention.
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